Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Markets for Image-Guided Surgery: Location, Location...and Guidance

This article was originally published in Start Up

Executive Summary

The market for image-guided surgical systems is worth $1.2 billion in 2005, according to a report recently issued by Medtech Insight, $1 billion attributable to interventional imaging, and $155.2 million to the sales of surgical navigation systems. The market is expected to experience a compound annual growth rate of 5.5% for the next several years, a slightly higher rate than the 4.1% forecast for the imaging industry as a whole.

You may also be interested in...

Praxim: Transforming Orthopedics Through Robotics

Robotic technology in orthopedics has been around for years, but with less than striking success. Now Praxim, a French surgical navigation technology company, believes it has solved the technical problems and has an "intelligent instrument" system that surgeons will be eager to adopt. Praxim argues that as OR technology advances, linking imaging, navigation, and computer-assisted intelligent instrumentation, robotic systems will represent not an adjunct technology play, but rather the centerpiece of an orthopedics offering.

Magnetic Moment

In terms of medical applications magnetic resonance imaging could serve, the modality is still underused, and that means a large, untapped growth opportunity for the entrenched large manufacturers that dominate the industry with an installed base of capital equipment. Small companies have a role to play as well, with adjunctive technologies that serve the large players, or in niches too small for the multi-billion dollar players to notice.

R2D2 in the OR

For years, robotic surgery was regarded skeptically as space-aged medicine. But a new generation of minimally-invasive procedures involving the reconstruction of delicate and critical body structures is giving life to this technology. Now the domain of small companies, signs of interest by large device companies could give this industry a major boost.


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts